QPX2015
/ Shionogi
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
October 07, 2020
Phase 1 Oral QPX7831 Alone (SAD, MAD) and Combined With QPX2015, Including Effect of Food, in Healthy Adults
(clinicaltrials.gov)
- P1; N=136; Not yet recruiting; Sponsor: Qpex Biopharma, Inc.
Clinical • Combination therapy • New P1 trial • Infectious Disease
October 24, 2019
Phase 1 Study of Oral QPX2015 in Healthy Adult Subjects
(clinicaltrials.gov)
- P1; N=40; Completed; Sponsor: Qpex Biopharma, Inc.; Recruiting ➔ Completed; Trial completion date: Feb 2020 ➔ Oct 2019; Trial primary completion date: Feb 2020 ➔ Oct 2019
Clinical • Trial completion • Trial completion date • Trial primary completion date
1 to 2
Of
2
Go to page
1